David Rabuka
Directeur Général chez Acrigen Biosciences, Inc.
Postes actifs de David Rabuka
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Acrigen Biosciences, Inc.
 Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Directeur Général | 01/01/2019 | - |
| Fondateur | 01/01/2019 | - | |
| President | 01/01/2019 | - |
Historique de carrière de David Rabuka
Anciens postes connus de David Rabuka
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | - | - |
Redwood Bioscience, Inc.
 Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Directeur Technique/Scientifique/R&D | 15/09/2011 | - |
| Fondateur | 01/01/2008 | - | |
| President | 17/10/2011 | - |
Formation de David Rabuka
| University of California, Berkeley | Doctorate Degree |
| University of Alberta | Graduate Degree |
| University of Saskatchewan | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
Opérationnelle
| Founder | 2 |
| President | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Redwood Bioscience, Inc.
Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Health Technology |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Acrigen Biosciences, Inc.
Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Health Technology |
- Bourse
- Insiders
- David Rabuka
- Expérience
